These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 4140237

  • 1. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M, Mickey MR, Terasaki PI.
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract] [Full Text] [Related]

  • 2. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P, Demaille A, Adenis L.
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract] [Full Text] [Related]

  • 3. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M, Kinoshita K.
    J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I, Hellström KE.
    Johns Hopkins Med J Suppl; 1974 Dec; 3():37-50. PubMed ID: 4608238
    [No Abstract] [Full Text] [Related]

  • 7. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET.
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract] [Full Text] [Related]

  • 8. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
    Bolton PM.
    Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933
    [No Abstract] [Full Text] [Related]

  • 9. HL-A antigens in solid tumors.
    Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW.
    Cancer Res; 1973 Apr; 33(4):648-50. PubMed ID: 4739655
    [No Abstract] [Full Text] [Related]

  • 10. Immunological activity of blood lymphocyte fractions. A study by the macrophage electrophoretic mobility method.
    Minderhoud JM, Smith JK.
    Clin Exp Immunol; 1972 Apr; 10(4):571-9. PubMed ID: 5034245
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunomorphologic changes in regional lymph nodes associated with cancer.
    Brynes RK, Hunter RL, Vellios F.
    Arch Pathol Lab Med; 1983 May; 107(5):217-21. PubMed ID: 6687668
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
    Cummings FJ, Heppner GH, Stolbach L, Calabresi P.
    Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
    [No Abstract] [Full Text] [Related]

  • 18. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M.
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.